Rare diseases
Investigational molecules
Locations
Comparing AZD5335 with mirvetuximab soravtansine or a drug combination in patients with platinum-resistant ovarian cancer
GreeceA study comparing Rinatabart Sesutecan to other treatments in patients with endometrial cancer who have previously received platinum-based chemotherapy and PD-L1 therapy
GreeceA study of PF-08634404 and a drug combination in adults with advanced or metastatic non-small cell lung cancer
GreeceA study to evaluate the safety and effectiveness of KPL-387 in patients with well-controlled recurrent pericarditis
GreeceA study to evaluate the safety and effectiveness of AZD0292 in people aged 12 years and older with bronchiectasis and chronic Pseudomonas aeruginosa infection
GreeceA study to evaluate the effectiveness of tenecteplase in patients with acute ischemic stroke who are more than 4.5 hours after their last known well time.
GreeceA study of the humanised IgG1 lalaps-yte monoclonal antibody against lysophosphatidic acid receptor 1 to treat adults with idiopathic pulmonary fibrosis
GreeceA study to evaluate the effectiveness and safety of remibrutinib in patients with secondary progressive multiple sclerosis
GreeceA study of MK-1084 and a drug combination for patients with advanced or metastatic non-small cell lung cancer with KRAS G12C mutations.
GreeceA study to evaluate the effect of orforglipron on cardiovascular health in adults with atherosclerotic cardiovascular disease and/or chronic kidney disease
GreeceA study of palazestrant and ribociclib compared to letrozole and ribociclib for patients with advanced ER+ HER2- breast cancer
GreeceA study to evaluate the safety and effectiveness of nucresiran and vutrisiran in patients with hereditary transthyretin amyloidosis with polyneuropathy
GreeceTell us about your condition – we search every trial in Europe and connect you with the right site.
